PRESS RELEASE published on 07/29/2025 at 14:08, 11 months 12 days ago Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority Viromed Medical AG's Annual General Meeting approves all proposed resolutions by a large majority. New Supervisory Board member elected, authorised capital replaced, and focus on innovation highlighted Annual General Meeting Resolutions Strategic Direction Viromed Medical AG Cold Plasma Technology
PRESS RELEASE published on 07/29/2025 at 14:00, 11 months 12 days ago Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101 Eckert & Ziegler chosen as US manufacturer for Archeus' ART-101 radiopharmaceutical, targeting prostate cancer. Collaboration to support Phase 1 trial with state-of-the-art facility in Boston, MA Eckert & Ziegler Prostate Cancer Radiopharmaceutical ART-101 Archeus
PRESS RELEASE published on 07/29/2025 at 14:00, 11 months 12 days ago Thermon(R) Introduces Poseidon(TM) and Pontus(TM) Liquid Load Banks: Revolutionizing Data Center Commissioning and Validation Thermon announces global availability of Poseidon™ and Pontus™ Liquid Load Banks for data center validation, designed for HPC environments Data Center Poséidon Thermon Liquid Load Banks Pontus
PRESS RELEASE published on 07/29/2025 at 14:00, 11 months 12 days ago bioEnergy Development Inc. Announces First Sale of Breakthrough Mobile Bioreactor for On-Site Waste-to-Energy Conversion bioEnergy Development Inc. sells first mobile bioreactor in Florida's equestrian industry, turning manure into energy and agricultural products, offering decentralized clean energy solutions Florida Waste-to-Energy Mobile Bioreactor Equestrian Industry BioEnergy Development Inc.
PRESS RELEASE published on 07/29/2025 at 14:00, 11 months 12 days ago Ovation Science Expands with Planet 13 into Florida Ovation Science expands license agreement with Planet 13 to bring Invisicare® topical cannabis products to Florida, leveraging Planet 13's extensive retail network License Agreement Planet 13 Ovation Science Florida Market Topical Products
PRESS RELEASE published on 07/29/2025 at 14:00, 11 months 12 days ago Trifecta Gold Provides Exploration Update from the Tombstone Gold Belt, Yukon Trifecta Gold provides exploration updates on Mt. Hinton and Rye projects in Yukon portion of Tombstone Gold Belt. Mt. Hinton drilling completed with 753m drilled. Rye Property granted drill permit Drilling Exploration Updates Trifecta Gold Mt. Hinton Rye Property
PRESS RELEASE published on 07/29/2025 at 13:55, 11 months 12 days ago H&R GmbH & Co. KGaA: H&R Holding GmbH Waives Minimum Acceptance Threshold in Tender Offer to Shareholders of H&R GmbH & Co. KGaA H&R Holding GmbH waives the minimum acceptance threshold in a tender offer to shareholders of H&R GmbH & Co. KGaA, providing increased transaction certainty. Shareholders can accept the offer until August 25, 2025 Shareholders Tender Offer Acceptance Threshold Transaction Certainty H&R Holding GmbH
PRESS RELEASE published on 07/29/2025 at 13:50, 11 months 12 days ago H&R Holding GmbH waives minimum acceptance threshold in public tender offer to the shareholders of H&R GmbH & Co. KGaA H&R Holding GmbH waives minimum acceptance threshold in public tender offer to the shareholders of H&R GmbH & Co. KGaA increasing transaction security and extending acceptance period until 25 August 2025 Shareholders Public Tender Offer H&R Holding GmbH Waives Minimum Acceptance Threshold
PRESS RELEASE published on 07/29/2025 at 13:30, 11 months 12 days ago Audited Annual Statements for the Fiscal Year ended March 31, 2025 Plaintree Systems Inc. releases audited financial statements for Fiscal Year 2025, reporting lower revenues and net loss. CEO highlights challenges due to geo-political factors Revenues Net Loss Plaintree Systems Inc. Audited Financial Statements Geo-political Challenges
PRESS RELEASE published on 07/29/2025 at 13:30, 11 months 12 days ago MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain MIRA Pharmaceuticals advances non-opioid oral drug Ketamir-2 for neuropathic pain, clears FDA IND for Phase 2a, demonstrates potent effects in preclinical studies FDA Preclinical Studies MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain
Published on 07/10/2026 at 14:20, 2 hours 11 minutes ago Giyani Announces Filing of Definitive Feasibility Study
Published on 07/10/2026 at 14:00, 2 hours 31 minutes ago Orogen Royalties Begins Trading on OTCQX Best Market
Published on 07/10/2026 at 13:30, 3 hours 1 minute ago Empress Announces Acquisition of North American Royalty Portfolio
Published on 07/10/2026 at 13:30, 3 hours 1 minute ago Caldwell Appoints John Blank as Chief Operating Officer and Names Regional Managing Partners
Published on 07/10/2026 at 15:39, 51 minutes ago Karsten Dümmler, founder and long-standing Chairman of the Management Board of Netfonds AG, is stepping down from the Supervisory Board at his own request
Published on 07/10/2026 at 15:26, 1 hour 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 07/10/2026 at 15:25, 1 hour 5 minutes ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 07/10/2026 at 15:24, 1 hour 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 07/10/2026 at 15:23, 1 hour 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 07/10/2026 at 10:34, 5 hours 56 minutes ago Number of shares and voting rights - June 2026 (In French only)
Published on 07/09/2026 at 18:00, 22 hours 31 minutes ago Second-quarter 2026 activity: +7% (vs. Q2 2025)
Published on 07/09/2026 at 18:00, 22 hours 31 minutes ago Half-year report on Deezer’s liquidity contract with BNP Paribas
Published on 07/09/2026 at 17:45, 22 hours 46 minutes ago Air Liquide to invest over 200M USD to support chemical manufacturing expansion in Texas
Published on 07/09/2026 at 15:50, 1 day ago Statement about the number of shares composing the share capital and the number of voting rights as of June 30, 2026